Click here to view the United Healthcare (UHC) Medical Policy Updates » December 2024 United…
BCBS Louisiana Medical Policy Updates – November 2024
Click here to view the Blue Cross Blue Shield BCBS Louisiana Medical Policy Updates »
November 2024 BCBS Louisiana Medical Policy Updates:
- Abaloparatide (Tymlos™)
- Ablation Procedures for Peripheral Neuromas
- Ablation Therapy for the Treatment of Chronic Rhinitis
- Allogeneic Pancreas Transplant
- Allograft Injection for Degenerative Disc Disease
- arilumab (Kevzara®)
- atidarsagene autotemcel (Lenmeldy™)
- Auricular Electrostimulation
- Autografts and Allografts in the Treatment of Focal Articular Cartilage Lesions
- Beta Interferons for the Treatment of Multiple Sclerosis
- Bisphosphonates (Oral)
- Bronchial Valves
- burosumab (Crysvita®)
- C1 Esterase Inhibitor (Berinert®)
- cladribine (Mavenclad®)
- Decompression of the Intervertebral Disc Using Laser Energy (Laser Discectomy) or Radiofrequency Coblation (Nucleoplasty)
- Diabetic Test Strips
- Electronic Brachytherapy for Nonmelanoma Skin Cancer
- etanercept (Enbrel®)
- Ethacrynic Acid Oral Products (Edecrin®, generics)
- Etranacogene Dezaparvovec (Hemgenix®)
- Experimental-Investigational Services
- Glatiramer acetate (Copaxone® )
- Hematopoietic Cell Transplantation for Non-Hodgkin Lymphomas
- Hip Resurfacing
- Icatibant (Firazyr®, generics)
- infliximab-dyyb (Zymfentra™)
- Itraconazole (Onmel® )
- Ivermectin Tablets (Stromectol® ,Generics)
- mavorixafor (Xolremdi™)
- Meniscal Allografts and Other Meniscal Implants
- Mifepristone (Korlym®)
- Modafinil (Provigil®)/Armodafinil (Nuvigil®)
- Noncontact Ultrasound Treatment for Wounds
- Ofatumumab (Kesimpta®)
- Overactive Bladder Medications (Branded)
- Pegylated Interferons (Pegasys® , PegIntron®) for Other (NonHepatitis C) Uses
- Phosphate Binders
- Photodynamic Therapy for Choroidal Neovascularization
- Risk-Reducing Mastectomy
- Saturation Biopsy for Diagnosis, Staging, and Management of Prostate Cancer
- Select Drug Quantity Management
- Select Fenofibrate Products
- Select Long-Acting Insulin Products
- Sensory Integration Therapy and Auditory Integration Therapy
- Sipuleucel-T (Provenge®
- Surgical Treatments for Breast Cancer−Related Lymphedema
- Tafamidis Products (Vyndaqel®, Vyndamax™)
- Teriflunomide (Aubagio®)
- Teriparatide Products
- Tofersen (Qalsody™)
- Transcranial Magnetic Stimulation as a Treatment of Depression and Other Psychiatric/Neurologic Disorders
- Treatment of Hepatitis C with a sofosbuvir (Sovaldi®) Based Regimen
- Treatment of Hepatitis C with elbasvir and grazoprevir (Zepatier®)
- Treatment of Hepatitis C with glecaprevir/pibrentasvir (Mavyret™)
- Treatment of Hepatitis C with ombitasvir, paritaprevir, ritonavir, and dasabuvir (Viekira Pak™)
- Treatment of Hepatitis C with sofosbuvir/ledipasvir (Harvoni®, Authorized Generic)
- Treatment of Hepatitis C with sofosbuvir/velpatasvir (Epclusa®, Authorized Generic)
- Tumor Treating Fields Therapy
- Veozah™ (Fezolinetant)
How Does Policy Alerts Work?
Policy Alerts’ medical policy monitoring and alerts software continuously monitors Commercial, Medicare, and Medicaid coverage information to keep you up-to-date on coverage changes in real-time.
Policy Alerts’ software locates relevant Payer medical policies and coverage information from across the web. This software monitors that information for updates and changes while also searching for new medical policies and coverage information. Whenever changes occur, Policy Alerts immediately sends out an email notification containing a summary of what has changed.
Clients can access their medical policies and payer coverage summary on the interactive Policy Alerts dashboard. Never miss another important insurance carrier medical policy review or coverage decision update again!
✓ Thousands of subscribers ✓ Easy setup